Followers | 237 |
Posts | 10817 |
Boards Moderated | 0 |
Alias Born | 07/17/2006 |
Wednesday, May 13, 2020 7:06:01 AM
First the facts..
Fact 1) Triglycerides (trigs) are a fraction of the blood lidids..they are three fatty acid chains tied together by a glycerol molecule...and as such are the main source of the bodies fuel..Even though diet and liver synthesis (trigs are synthesized by the liver) can increase blood trig levels..Trig levels are mainly controlled by the rate they are removed from the blood stream...From a clinical standpoint when and if a patient has high trigs..it is not because he is eating too many fats its because he can not dissolve the trigs out of his blood stream and store them in his body fat...
Fact 2)..All fats are lipids and not soluble in aqueous solutions like the blood...Therefore they must be transported in lipoproteins that have a polar external surface and a non polar internal surface..The lipoprotein which carries pricipally trigs is the Very Low Density Lipoprotein (VLDL) fraction. The VLDL fraction also carries some LDL-C and as such is defined principally by the cargo it carries..The confusion here is created by the fact that if the VLDL particle loses a significant fraction of its trigs.(50%) then it is no longer a VLDL particle, but is converted into a LDL particle..And this is why lowering trigs in most cases results in an increase in LDL particles..
Fact 3)..There is an equation (The Friedewald Equation) which defines the correct ratios of the main lipid components of the blood..The Friedewald equation has been determined in large clinical studies (30 thousand patients) to very accurate although it does require some changes in the constant at very high trig levels..
The Friedwald Equation says LDL = TotalChol - (Triglycerides / 5) - HDL
From this very simple algebraic formula we can see that if all other parameters remain constant then lowering the trigs by any method should cause an increase in LDL. LDL being a well known risk factor now and back in the early 2000s it seems obvious that if EPA lowered the trig level it must increase the LDL...The fact it did not was anything but obvious and is still not obvious 20 years later...it is a mystery to most..
The reason why EPA could lower Trig levels and not raise LDL could be because EPA lowers Trigs by lowering Systemic Inflammation (SI)..As noted earlier trig levels are controlled mainly by the rate trigs are removed from the blood stream and not by the rate they are introduced into the blood stream and this is very similar to how blood sugar levels are controlled by the body..
In type 2 Diabetes...the root problem is the patient's insulin is not very efficient at removing sugar from the blood stream..A situation called "Insulin Resistance" (IR)..It is a proven fact that IR is the direct result of elevated SI...Elevated trigs result in a similar fashion to those seen in the blood sugar in t2DM because the enzymes that expedite the removal of trigs from the blood (Fatty acid synthases) (FAS) are effected by elevated SI in the same way Insulin is effected in T2DM...In both cases the culprit is elevated Systemic Inflammation..So elevated blood sugar in T2DM is a marker for elevated SI and elevated trigs are also a marker for SI..And as we on this board understand elevated SI is what causes the events in Cardiac and vascular diseases..
So there was no obviousness about the Marine results back in 2010..Ten years later and it is still a puzzle..Lowering trigs and not significantly rising LDL-C..should not be possible..Most likely there is a statin like effect resulting from the lowering of SI..
Du and even Fisher and certainly the other judges are way over their heads on these issues. There was no obviousness and still no obviousness.
Mother medicine can hold on to her secrets..The questions never change..only the answers...
":>) JL
Recent AMRN News
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:00:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:31:21 PM
- Amarin Chairman & CEO Issue Letter to Shareholders • GlobeNewswire Inc. • 01/22/2024 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM